In this study, we demonstrated changes in metastatic capacity of PCa cell lines related with the expression of UBXN1 and ARRDC4, supporting the evidence that they may serve as potential prognostic biomarkers for PCa. This evidence concerns the gene UBXN1 and posterior cortical atrophy.